Kidney Cancer Clinical Trial

Clinical Trial Finder Kidney Cancer Trials

Impact of C-arm CT in Decreased Renal Function Undergoing TACE for Tx of Hepato-Cellular Carcinoma

See Locations Near You

Summary

Impact on contrast dose or total volume of contrast required to effectively treat the targeted tumor.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Patients must be affected by HCC
Patients must have diminished renal function (GFR<60 ml/min/1.73m^2)
Patients must be 18 years old or older
Patients must have received an abdominal CT, PET/CT scan or MRI, completed prior to the TACE procedure.
Ability to understand and the willingness to sign a written informed consent document.

Exclusion Criteria:

Subjects under the age of 18
Patients currently on dialysis
Pregnant women

Study is for people with:

Kidney Cancer

Estimated Enrollment:

13

Study ID:

NCT01326390

Recruitment Status:

Terminated

Sponsor:

Stanford University

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Stanford University School of Medicine
Stanford California, 94305, United States

How clear is this clinincal trial information?

Study is for people with:

Kidney Cancer

Estimated Enrollment:

13

Study ID:

NCT01326390

Recruitment Status:

Terminated

Sponsor:


Stanford University

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider